期刊文献+

尘肺患者肺段灌洗治疗临床疗效观察 被引量:6

Clinical Effects of Bronchopulmonary Lavage in Patients with Pneumoconiosis
原文传递
导出
摘要 目的观察尘肺合并感染患者支气管肺段灌洗治疗临床疗效。方法选择70例急性期尘肺患者,随机分为实验组(35例)和对照组(35例)。两组同等病情住院期间接受常规治疗(抗感染、止咳祛痰平喘)。实验组在常规治疗的基础上加支气管肺段灌洗治疗,设计疗程为单个治疗疗程。观察两组患者支气管镜检结果、肺功能、血气分析各参数值变化,作统计学分析。结果实验组患者支气管镜检结果、肺功能、血气分析各参数指标与对照组比较差异有统计学意义(P<0.05),且无明显不良反应。结论尘肺患者支气管肺段灌洗治疗能有效改善尘肺急性加重期患者临床疗效指标,提高患者的生活质量。 Objective To observe the clinical effect of bronchopulmonary lavage therapy for the patients with pneumoconiosis complicated with infection. Methods All 60 acute stage patients with pneumoconiosis were randomly divided into the experimen-tal group(30 cases) and control group(30 cases). Both groups received the conventional therapy such as anti-infection, antitus- sive, expectorant and antiasthmatic treatment; the experimental group also received the bronchopulmonary lavage treatment. The bronchoscopy findings, pulmonary function, blood gas analysis parameters in both groups were recorded and statistically analyzed. Results The differences in all tested parameters were statistical significance between the two groups ( P 〈 0.05 ), and no obvious adverse reaction was found in the experimental group. Conclusion The bronchopulmonary lavage therapy can improve the clini-cal indicators in acute exacerbations of pneumoconiosis, and improve the QOL of patients.
出处 《中华全科医学》 2013年第2期206-207,共2页 Chinese Journal of General Practice
关键词 尘肺患者 基础治疗 支气管肺段灌洗 临床疗效 Patients with pneumoconiosis Conventional treatment Bronchopulmonary lavage Clinical curative effect
  • 相关文献

参考文献10

二级参考文献18

  • 1上海市医学会肺科学会肺部感染与肺间质性疾病学组.呼吸机相关肺炎[J].中华结核和呼吸杂志,1998,21:537-537.
  • 2支气管哮喘防治指南.支气管哮喘的定义、诊断、治疗、疗效判断标准及教育和管理方案[J].中华结核和呼吸杂志,1997,20:261-267.
  • 3Pizzichini MMM, Popov TA, Efthimiadis A, et al. Spontaneous and induced sputum to measure indices of airway inflammation in asthma[J]. Am J Respir Crit Care Med,1996,154:866-869.
  • 4Wark PA, Gibson PG, Fakes K. Induced sputum eosinophils in the assessment of asthma and chronic cough[J]. Respirology, 2000,5(1):51-57.
  • 5Yamamoto C,Yoneda T,Yoshikawa M,et al. Airway inflammation in COPD assessed by sputum levels of interleukin-8[J]. Chest,1997,112 (2):505-510.
  • 6Bhowmik A,Seemungal TA,Sapsford RJ,et al. Relation of sputum inflammatory markers to symptoms and lung function changes in COPD exacerbations[J]. Thorax, 2000,55 (2):114-120.
  • 7RELLO J, AUSINA V, RICART M, et al. Impact of previous antimicrebial therapy on the etiology and outcome of ventilator-associated pneumonia [J]. Chest, 1993, 104(4): 1230.
  • 8Louis RE, Cataldo D, Buckley MG, et al. Evidence of mast-cell activation in a subset of patients with eosinophilic chronic obstructive pulmonary disease. Eur Respir J,2002, 20: 325-331.
  • 9Dent G, Hadjicharalambous C, Yoshikawa T, et al. Contribution of eotaxin-1 to eosinophil chemotactic activity of moderate and severe asthmatic sputum. Am J Respir Crit Care Med, 2004, 169: 1110-1117.
  • 10慢性阻塞性肺疾病(COPD)诊治规范(草案)[J].中华结核和呼吸杂志,1997,20(4):199-203. 被引量:1381

共引文献70

同被引文献42

引证文献6

二级引证文献45

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部